91Ó°ÊÓ

: For a vaccine to be effective, it needs to contain some key components that help the immune system recognize and fight off the specific pathogens (disease-causing organisms). These components include: a) Antigens: These are foreign substances from the pathogens, such as proteins or sugars, that trigger an immune response upon entering the body. The antigens in vaccines can come from weakened or inactivated pathogens or even from purified parts of the pathogens. b) Adjuvants: These are substances added to vaccines to improve the body's immune response to antigens. Adjuvants increase the effectiveness of vaccines by stimulating the immune system, making it more likely to produce a strong and lasting immune response. c) Stabilizers: These are substances added to vaccines to maintain their effectiveness during transport and storage. Stabilizers keep the vaccine components stable and prevent them from breaking down when exposed to changes in temperature, light or humidity. d) Preservatives: These are used in some vaccines to prevent bacterial or fungal contamination during production, storage and transport.

: There are several reasons for the absence of a vaccine for HIV: a) High mutation rate: HIV mutates rapidly, which means that it continuously changes its genetic makeup. As a result, the immune system faces difficulty in recognizing and fighting off the virus. This also makes it challenging to develop a vaccine that effectively targets all HIV strains. b) Unique immune evasion mechanisms: HIV has developed ways to evade the host's immune system, such as attacking the very immune cells (CD4+ T-cells) that are supposed to protect the body against the virus. This greatly complicates the development of an effective vaccine. c) Limited animal models: The development of vaccines often involves testing them in animal models before human trials. However, HIV primarily infects humans, making it difficult to find appropriate animal models for HIV vaccine development. d) Lack of immune correlates of protection: In order to develop an effective vaccine, scientists need to understand the specific immune responses that lead to protection against an infection. However, the immune responses that provide protection against HIV are not yet fully understood. e) Safety concerns: As HIV is a life-long and potentially fatal infection, vaccines against HIV must be extremely safe. Some early HIV vaccine candidates resulted in enhanced infection rates in certain populations, raising concerns about safety and making the development process more cautious.